1. Huang D, Liu Z, Deng Y. Retinopathy of Prematurity (ROP): An Overview of Biomarkers in Various Samples for Prediction, Diagnosis, and Prognosis. Clinical Ophthalmology. 2025:1515-30. https://doi.org/ 10.2147/OPTH.S519292. [
DOI:10.2147/OPTH.S519292.]
2. Silva LS, Mendonça AC, Albano PD. Risk factors for retinopathy of prematurity in preterm newborns from a Brazilian maternity hospital: a cross-sectional study (2014-2022). Caderno Pedagógico. 2025;22(7):e16446-e.
3. Barresi C, Abdelmassih Y, Caputo G. Pediatric and developmental conditions. Ultra Widefield Imaging of the Retina: Elsevier; 2025. p. 135-80.
4. Elamurugan V, Narendran S, Varshney T, Babu KN, Rajan RP, Shankaralingappa P, et al. Topical application of Ringer’s lactate for Stage 1 Retinopathy of Prematurity: A potential treatment hypothesis. Medical Hypotheses. 2025;194:111523.
5. Rashidian P, Karami S, Salehi SA. A review on retinopathy of prematurity. Medical Hypothesis, Discovery and Innovation in Ophthalmology. 2025;13(4):201. https://doi.org/ 10.51329/mehdiophthal1511. [
DOI:10.51329/mehdiophthal1511.]
6. Habibi MRM, JafariMoghadam A, Norouzkhani N, Nazari E, Imani B, Kheirdoust A, et al. The use of neural networks to determine factors affecting the severity and extent of retinopathy in preterm infants. International Journal of Retina and Vitreous. 2025;11(1):30. https://doi.org/ 10.1186/s40942-025-00650-z. [
DOI:10.1186/s40942-025-00650-z.]
7. Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Chan RP, Berrocal A, et al. International classification of retinopathy of prematurity. Ophthalmology. 2021;128(10):e51-e68. https://doi.org/ 10.1016/j.ophtha.2021.05.031. [
DOI:10.1016/j.ophtha.2021.05.031.]
8. Yonekawa Y, Thomas BJ, Thanos A, Todorich B, Drenser KA, Trese MT, et al. The cutting edge of retinopathy of prematurity care: expanding the boundaries of diagnosis and treatment. Retina. 2017;37(12):2208-25.
9. Camacho-Martinez E, Torres-Navarro K, Narvaez-Albarracin M, Kuzhda IM, Ramirez-Ortiz MA. Retinopathy of prematurity: Current status, treatment, prevention, and future directions from the perspective of developing countries. Kerala Journal of Ophthalmology. 2021;33(2):112-22. https://doi.org/ 10.1097/IAE.0000000000001719. [
DOI:10.1097/IAE.0000000000001719.]
10. Motamed-Gorji N, Abri Aghdam K, Ashrafi E, Parvaresh M-M. Retinopathy of Prematurity in Iran. Archives of Persian Ophthalmology. 2020;1:33-65.
11. Zepeda-Romero LC, Barrera-de-Leon JC, Camacho-Choza C, Gonzalez Bernal C, Camarena-Garcia E, Diaz-Alatorre C, et al. Retinopathy of prematurity as a major cause of severe visual impairment and blindness in children in schools for the blind in Guadalajara city, Mexico. Br J Ophthalmol. 2011;95(11):1502-5. https://doi.org/ 10.1136/bjophthalmol-2011-300015. [
DOI:10.1136/bjophthalmol-2011-300015.]
12. Rahi JS, Logan S, Timms C, Russell-Eggitt I, Taylor D. Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population-based study. The Lancet. 2002;360(9333):597-602. https://doi.org/ 10.1016/s0140-6736(02)09782-9. [
DOI:10.1016/s0140-6736(02)09782-9.]
13. Wylezinski LS, Gray JD, Polk JB, Harmata AJ, Spurlock III CF. Illuminating an invisible epidemic: a systemic review of the clinical and economic benefits of early diagnosis and treatment in inflammatory disease and related syndromes. Journal of clinical medicine. 2019;8(4):493. https://doi.org/ 10.3390/jcm8040493. [
DOI:10.3390/jcm8040493.]
14. Azami M, Jaafari Z, Rahmati S, Farahani AD, Badfar G. Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis. BMC ophthalmology. 2018;18:1-14. https://doi.org/ 10.1186/s12886-018-0732-3. [
DOI:10.1186/s12886-018-0732-3.]
15. Bas AY, Demirel N, Koc E, Isik DU, Hirfanoglu İM, Tunc T. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units. British journal of ophthalmology. 2018;102(12):1711-6. https://doi.org/ 10.1136/bjophthalmol-2017-311789. [
DOI:10.1136/bjophthalmol-2017-311789.]
16. Waheeb S, Alshehri K. Incidence of retinopathy of prematurity at two tertiary centers in Jeddah, Saudi Arabia. Saudi Journal of Ophthalmology. 2016;30(2):109-12. https://doi.org/ 10.1016/j.sjopt.2016.02.006. [
DOI:10.1016/j.sjopt.2016.02.006.]
17. Gerull R, Brauer V, Bassler D, Laubscher B, Pfister RE, Nelle M, et al. Incidence of retinopathy of prematurity (ROP) and ROP treatment in Switzerland 2006–2015: a population-based analysis. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2018;103(4):F337-F42. https://doi.org/ 10.1136/archdischild-2017-313574. [
DOI:10.1136/archdischild-2017-313574.]
18. Ludwig CA, Chen TA, Hernandez-Boussard T, Moshfeghi AA, Moshfeghi DM. The epidemiology of retinopathy of prematurity in the United States. Ophthalmic surgery, lasers & imaging retina. 2017;48(7):553. https://doi.org/ 10.3928/23258160-20170630-06. [
DOI:10.3928/23258160-20170630-06.]
19. Asferaw M, Woodruff G, Gilbert C. Causes of severe visual impairment and blindness in students in schools for the blind in Northwest Ethiopia. BMJ global health. 2017;2(2):e000264. https://doi.org/ 10.1136/bmjgh-2016-000264. [
DOI:10.1136/bmjgh-2016-000264.]
20. Gudlavalleti VSM. Magnitude and temporal trends in avoidable blindness in children (ABC) in India. The Indian Journal of Pediatrics. 2017;84:924-9. https://doi.org/ 10.1007/s12098-017-2405-2. [
DOI:10.1007/s12098-017-2405-2.]
21. Hwang JH, Lee EH, Kim EA-R. Retinopathy of prematurity among very-low-birth-weight infants in Korea: incidence, treatment, and risk factors. Journal of Korean medical science. 2015;30(Suppl 1):S88. https://doi.org/ 10.3346/jkms.2015.30.S1.S88. [
DOI:10.3346/jkms.2015.30.S1.S88.]
22. Solebo AL, Teoh L, Rahi J. Epidemiology of blindness in children. Archives of disease in childhood. 2017;102(9):853-7. https://doi.org/ 10.1136/archdischild-2016-310532. [
DOI:10.1136/archdischild-2016-310532.]
23. Ozturk T, Er D, Yaman A, Berk AT. Changing trends over the last decade in the aetiology of childhood blindness: a study from a tertiary referral centre. British Journal of Ophthalmology. 2016;100(2):166-71. https://doi.org/ 10.1136/bjophthalmol-2015-306737. [
DOI:10.1136/bjophthalmol-2015-306737.]
24. Peirovifar A, Gharehbaghi MM, Gharabaghi PM, Sadeghi K. Vascular endothelial growth factor and insulin-like growth factor-1 in preterm infants with retinopathy of prematurity. Singapore Med J. 2013;54(12):709-12. https://doi.org/ 10.11622/smedj.2013246. [
DOI:10.11622/smedj.2013246.]
25. Khatami SF, YOUSEFI AE, FATEHI BGA, MAMOURI GA. Retinopathy of prematurity among 1000-2000 gram birth weight newborn infants. 2008.
26. Yaghoubi GH, Heydari B, Faal G, Heydari E, Alipour M. Prevalence and related factors of retinopathy of prematurity (ROP) in preterm infants in ophthalmology clinic of Birjand University of Medical Science from 2014 to 2016. Journal of Surgery and Trauma. 2017;5(3):62-6.